StockData

Bon Natural Life Ltd (BON) stock

BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026Score 0/30
$1.04−0.03 (-2.80%)

Close on Nov 18, 2026Market cap $8.45MP/E –Yield –

Bon Natural Life revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $18.67M, down 21.7% from the year before. The highest annual figure on record is $29.91M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Sep 30, 2025$18.67M-21.7%
FY2024Sep 30, 2024$23.84M-19.2%
FY2023Sep 30, 2023$29.52M-1.3%
FY2022Sep 30, 2022$29.91M+17.3%
FY2021Sep 30, 2021$25.49M+39.9%
FY2020Sep 30, 2020$18.22M+11.1%
FY2019Sep 30, 2019$16.40M–

More Bon Natural Life figures

See a number that looks wrong?